The AIR Site Alliance serves as a blueprint for industry players to facilitate patient participation in clinical trials regardless of where they live, work, or receive medical care. The collective efforts of the AIR Site Alliance provide a practical model for making clinical research more accessible and innovative.
At Genentech, we understand health inequities are complex and cannot be solved overnight. Best practices established through the creation of the AIR Site Alliance model can be leveraged across the healthcare landscape to encourage inclusive behavior, such as enrolling diverse patient groups in clinical studies and delivering medicines to patients who need them most.
As the US Alliance yielded successful results, in partnership with the Roche group, we’ve expanded to seven other countries: South Africa, the United Kingdom, Kenya, Morocco, India, Nigeria, and Canada.
